Literature DB >> 1492573

Hypothermia ameliorates neuronal survival when induced 2 hours after ischaemia in the rat.

C Coimbra1, T Wieloch.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1492573     DOI: 10.1111/j.1748-1716.1992.tb09462.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


× No keyword cloud information.
  7 in total

1.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 2.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

Review 3.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

4.  Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions.

Authors:  M Herrera-Marschitz; C F Loidl; Z B You; K Andersson; R Silveira; W T O'Connor; M Goiny
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 5.  Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

6.  Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient cerebral ischemia.

Authors:  C Coimbra; T Wieloch
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial.

Authors:  Dennis Azzopardi; Peter Brocklehurst; David Edwards; Henry Halliday; Malcolm Levene; Marianne Thoresen; Andrew Whitelaw
Journal:  BMC Pediatr       Date:  2008-04-30       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.